When IGF‐I was analysed as a continuous variable, the association between circulating concentrations of IGF‐I and bladder cancer risk remained non‐significant (OR1SD = 0.97; 95% CI: 0.87–1.08; ptrend = 0.60). Here, IGF1 is linked to urinary bladder carcinoma.